In Brief: Mosaic Gains Two Clinical-Stage Oncology Assets From Astex

With This In-Licensing, Mosaic Evolves Into A Clinical-Stage Oncology Player

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.